« Back to Record
Citation APA

Lambertini, M., Agbor‑Tarh, D., Metzger-Filho, O., Pondé, N., Poggio, F., Hilbers, F. F., Korde, L., Chumsri, S., Werner, O., Del Mastro, L., Caparica Bitton, R., Moebus, V., Moreno-Aspitia, A., Piccart-Gebhart, M., & de Azambuja, E. (2020). Prognostic role of distant disease-free interval from completion of adjuvant trastuzumab in HER2-positive early breast cancer: Analysis from the ALTTO (BIG 2-06) trial. ESMO Open, 5(6), e000979. doi:10.1136/esmoopen-2020-000979


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/315199

Lambertini, M., Agbor‑Tarh, D., Metzger-Filho, O., Pondé, N., Poggio, F., Hilbers, F. F., Korde, L., Chumsri, S., Werner, O., Del Mastro, L., Caparica Bitton, R., Moebus, V., Moreno-Aspitia, A., Piccart-Gebhart, M., & de Azambuja, E. (2020). Prognostic role of distant disease-free interval from completion of adjuvant trastuzumab in HER2-positive early breast cancer: Analysis from the ALTTO (BIG 2-06) trial. ESMO Open, 5(6), e000979. doi:10.1136/esmoopen-2020-000979